DAFLON 500 mg COMPRIMIDOS RECUBIERTOS
DAFLON 500 mg COMPRIMIDOS RECUBIERTOS
Commercialized
Register Number
1-20685IP
Prescription Type
Sin Receta
Authorization Date
Jul 13, 2020
Dosage Form
COMPRIMIDO RECUBIERTO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1-20685IP
EMA Approved
No
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
DIOSMINAActive
Quantity: 450 mg
Name: DIOSMINA
HESPERIDINAActive
Quantity: 50 mg
Name: HESPERIDINA
ATC CLASSIFICATION (3)
C05C
C05CA
C05CA53